Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Celine Gongora"'
Autor:
Alexandra Fauvre, Margot Machu, Audrey Merienne, Nadia Vie, Thomas Bessede, Mathilde Robin, Veronique Garambois, Clara Taffoni, Nadine Laguette, Nadine Gervois‐Segain, Anne Jarry, Nathalie Labarriere, Yves Allory, Christel Larbouret, Laurent Gros, Diego Tosi, David B. Solit, Philippe Pourquier, Nadine Houédé, Celine Gongora
Publikováno v:
Clinical and Translational Medicine, Vol 14, Iss 9, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/909d3363b27643e8a03718ec78c8c871
Autor:
Emilia Rabia, Véronique Garambois, Julie Hubert, Marine Bruciamacchie, Nelly Pirot, Hélène Delpech, Morgane Broyon, Charles Theillet, Pierre-Emmanuel Colombo, Nadia Vie, Diego Tosi, Celine Gongora, Lakhdar Khellaf, Marta Jarlier, Nina Radosevic-Robin, Thierry Chardès, André Pèlegrin, Christel Larbouret
Publikováno v:
mAbs, Vol 13, Iss 1 (2021)
Chemoresistance, particularly to gemcitabine, is a major challenge in pancreatic cancer. The epidermal growth factor receptor (EGFR) and human epidermal growth factor receptors 2 and 3 (HER2, HER3) are expressed in many tumors, and they are relevant
Externí odkaz:
https://doaj.org/article/321dae94e99e49a6a55ffcb4d608277f
Autor:
Fanny Leenhardt, Frédéric Fiteni, Ludovic Gauthier, Marie Alexandre, Séverine Guiu, Nelly Firmin, Stéphane Pouderoux, Marie Viala, Gerald Lossaint, Chloé Gautier, Caroline Mollevi, Matthieu Gracia, Celine Gongora, Litaty Mbatchi, Alexandre Evrard, William Jacot
Publikováno v:
Pharmaceutics, Vol 14, Iss 4, p 841 (2022)
Palbociclib is a good candidate for therapeutic drug monitoring (TDM) due to its narrow therapeutic range and frequency of toxicities, particularly high-grade neutropenia. In this prospective, bicentric clinical trial, we evaluated the palbociclib ex
Externí odkaz:
https://doaj.org/article/d52b956fb3394cc7bed5973cee308283
Autor:
Florent Mouliere, Bruno Robert, Erika Arnau Peyrotte, Maguy Del Rio, Marc Ychou, Franck Molina, Celine Gongora, Alain R Thierry
Publikováno v:
PLoS ONE, Vol 6, Iss 9, p e23418 (2011)
BACKGROUND: Circulating DNA (ctDNA) is acknowledged as a potential diagnostic tool for various cancers including colorectal cancer, especially when considering the detection of mutations. Certainly due to lack of normalization of the experimental con
Externí odkaz:
https://doaj.org/article/4ced5a5d82c44141b2f467d0a1ad9f20
Autor:
Celine Gongora, Nadia Vezzio-Vie, Roderick L. Beijersbergen, Maguy Del Rio, Pierre Martineau, Jerome Moreaux, Nathalie Bonnefoy, Philippe Pasero, Arnaud Coquelle, Marta Jarlier, Delphine Desigaud, Veronique Garambois, Flavie Coquel, Henri-Alexandre Michaud, Diego Tosi, Augusto F. Andrade, Eve Combès
Oxaliplatin combined with the ATR inhibitor VE-822 induces immune death signalling
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1967a627961a165c7e604fc22df7e2d
https://doi.org/10.1158/0008-5472.22420949
https://doi.org/10.1158/0008-5472.22420949
Autor:
Celine Gongora, Nadia Vezzio-Vie, Roderick L. Beijersbergen, Maguy Del Rio, Pierre Martineau, Jerome Moreaux, Nathalie Bonnefoy, Philippe Pasero, Arnaud Coquelle, Marta Jarlier, Delphine Desigaud, Veronique Garambois, Flavie Coquel, Henri-Alexandre Michaud, Diego Tosi, Augusto F. Andrade, Eve Combès
Although many patients with colorectal cancer initially respond to the chemotherapeutic agent oxaliplatin, acquired resistance to this treatment remains a major challenge to the long-term management of this disease. To identify molecular targets of o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cc9ed29041f254d948ae7a38444cd60
https://doi.org/10.1158/0008-5472.c.6510791.v1
https://doi.org/10.1158/0008-5472.c.6510791.v1
Autor:
Celine Gongora, Nadia Vezzio-Vie, Roderick L. Beijersbergen, Maguy Del Rio, Pierre Martineau, Jerome Moreaux, Nathalie Bonnefoy, Philippe Pasero, Arnaud Coquelle, Marta Jarlier, Delphine Desigaud, Veronique Garambois, Flavie Coquel, Henri-Alexandre Michaud, Diego Tosi, Augusto F. Andrade, Eve Combès
Effect of ATR inhibition combined with oxaliplatin treatment on the ATR and ATM pathways.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7fab0aebbf41895d5bdd5b30bd5bf75
https://doi.org/10.1158/0008-5472.22420955.v1
https://doi.org/10.1158/0008-5472.22420955.v1
Autor:
Celine Gongora, Nadia Vezzio-Vie, Roderick L. Beijersbergen, Maguy Del Rio, Pierre Martineau, Jerome Moreaux, Nathalie Bonnefoy, Philippe Pasero, Arnaud Coquelle, Marta Jarlier, Delphine Desigaud, Veronique Garambois, Flavie Coquel, Henri-Alexandre Michaud, Diego Tosi, Augusto F. Andrade, Eve Combès
Molecular characteriistics of cell lines used in the study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17b28f2922d527d97c5cc1aebba6cac9
https://doi.org/10.1158/0008-5472.22420946.v1
https://doi.org/10.1158/0008-5472.22420946.v1
Autor:
Fanny Leenhardt, Frédéric Fiteni, Ludovic Gauthier, Marie Alexandre, Séverine Guiu, Nelly Firmin, Stéphane Pouderoux, Chloé Gautier, Gerald Lossaint, Alexandre Payen, Celine Gongora, Litaty Mbatchi, Alexandre Evrard, William Jacot
Publikováno v:
Cancer Research. 82:P5-13
Introduction CDK4/6 inhibitors, such as palbociclib, are prescribed in association with hormonal therapy in metastatic breast cancer patients. In Phase II/III studies, high neutropenia occurred in more than one in two patients leading to significant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae00d5fd4c313395cbd7df4279933dcb
https://doi.org/10.1158/1538-7445.sabcs21-p5-13-23
https://doi.org/10.1158/1538-7445.sabcs21-p5-13-23
Autor:
Clara Taffoni, Johanna Marines, Hanane Chamma, Soumyabrata Guha, Mathilde Saccas, Amel Bouzid, Ana‐Luiza Chaves Valadao, Clément Maghe, Jane Jardine, Mi Kyung Park, Katarzyna Polak, Mara De Martino, Claire Vanpouille‐Box, Maguy Del Rio, Celine Gongora, Julie Gavard, Nicolas Bidère, Min Sup Song, Donovan Pineau, Jean‐Philippe Hugnot, Karima Kissa, Laura Fontenille, Fabien P Blanchet, Isabelle K Vila, Nadine Laguette
Publikováno v:
EMBO Journal
EMBO Journal, 2023, 42 (7), pp.e111961. ⟨10.15252/embj.2022111961⟩
EMBO Journal, 2023, 42 (7), pp.e111961. ⟨10.15252/embj.2022111961⟩
International audience; Cytosolic DNA promotes inflammatory responses upon detection by the cyclic GMP-AMP (cGAMP) synthase (cGAS). It has been suggested that cGAS downregulation is an immune escape strategy harnessed by tumor cells. Here, we used gl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fca26b903f9efbbb31d2dc98e01baca2
https://doi.org/10.15252/embj.2022111961
https://doi.org/10.15252/embj.2022111961